Decoding Biology Through Imaging Technologies and Machine Learning to Discover New Classes of Anti-infectives
ArrePath aims to be a leader in the discovery and development of new classes of anti-infectives through deep biological insights of cell behavior and the application of its machine learning and imaging-based platform.
ArrePath Technology and Pipeline
We are evolving our machine learning and artificial intelligence technologies and building a pipeline of anti-infective programs representing under- and unexploited mechanisms of action with high potential of clinical utility.
Expand our anti-infectives pipeline through new screening methodologies coupled with ArrePath’s ML-based imaging technologies.
Optimize and advance hits from our initial screening efforts through the pipeline to preclinical development candidate stage.
Integrate and industrialize our imaging-based technology platform, fully leveraging its potential in drug discovery.
Evolve the application of machine learning and artificial intelligence in the discovery and development of new anti-infectives.
Connect With Us
Interested in learning more about our strategy, or in discussing a
partnership? Contact us to get the conversation started.